Congress proposes rules requiring pharmacies to provide birth control without delay or transfer prescriptions
Also known as: Access to Birth Control Act
Impacts
State Impacts
The findings cite reports in Alabama of pharmacists refusing contraception. If enacted, pharmacies in Alabama that stock contraception would have to provide in-stock products without delay, offer transfer/referral or expedited ordering when out of stock, and avoid intimidation or privacy threats—while still allowing refusals for no prescription, inability to pay, or professional clinical judgment.
Arizona is named in the findings as a state with reported refusals. If enacted, pharmacies that stock contraception would need to dispense without delay and provide quick options when out of stock, with penalties and private lawsuits for violations, but the bill still allows refusal without a valid prescription (when required), inability to pay, or professional clinical judgment.
California is listed in the findings as having reports of refusals. The bill would set a federal baseline and explicitly allows stronger state protections to remain in place, so California could keep any stricter rules while pharmacies also comply with the new federal duties and enforcement exposure.
The District of Columbia is named in the findings as a place with reported refusals. If enacted, pharmacies that stock contraception in DC would have federal duties to dispense without delay, offer transfer/referral or expedited ordering when out of stock, and protect customers from harassment and privacy threats, with penalties and lawsuits for violations.
Georgia is cited in the findings for reported refusals. The bill would require pharmacies that stock contraception to provide it without delay when in stock and to offer quick transfer/referral or expedited ordering when out of stock, backed by penalties and private lawsuits, while keeping common refusal reasons (no prescription, can’t pay, clinical judgment).
Illinois is listed in the findings as having reports of refusals. If enacted, pharmacies that stock contraception would need to dispense without delay and provide quick options when out of stock, and Illinois could keep stronger customer protections because the bill does not override tougher state rules.
Louisiana is named in the findings as a state with reported refusals. The bill would create enforceable duties for pharmacies that stock contraception, including no-delay dispensing for in-stock products and quick transfer/referral or expedited ordering when out of stock, plus penalties and private lawsuits for violations.
Massachusetts is listed in the findings as a state with reported refusals. If enacted, pharmacies that stock contraception would have federal duties to avoid delaying or obstructing access and to protect privacy; Massachusetts could still enforce stronger protections under state law if they exist.
Michigan is named in the findings for reported refusals. The bill would require pharmacies that stock contraception to provide in-stock products without delay, offer transfer/referral or expedited ordering when out of stock, and avoid harassment or privacy threats, with penalties and private lawsuits for violations.
Minnesota is cited in the findings as a state with reported refusals. If enacted, pharmacies that stock contraception would be required to dispense without delay and give quick alternatives when out of stock, and Minnesota could keep any stronger state-level customer protections.
Key Points
- Pharmacies that stock birth control would have to provide it without delay when a customer requests it and it’s in stock.
- If birth control is out of stock, a pharmacy that normally carries it would have to quickly offer options: transfer you to a nearby pharmacy that has it, or rush-order it.
- The bill would bar pharmacy staff from intimidating or harassing customers, lying about availability or how birth control works, or threatening privacy about a request.
- Pharmacies could still refuse in limited cases, like no valid prescription (when required), inability to pay, or a clinical judgment by the employee.
- Enforcement would include federal civil penalties up to $1,000 per day (with a $100,000 cap per case) and the right for harmed customers to sue the pharmacy for relief and damages.
Milestones
Star Print ordered on the bill.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
What Happens Next
Projected impacts based on AI analysis
Customers can start bringing lawsuits for violations within a 5-year window.
If a pharmacy refuses, delays, lies about availability, or threatens privacy in ways covered by the bill, an affected person could sue for relief like damages and attorney fees (subject to what a court awards).
Civil penalties can be assessed for pharmacies found in violation.
Pharmacies that don’t comply could face federal penalties up to $1,000 per day (up to $100,000 per proceeding), which may push chains and independent pharmacies to tighten training and procedures.
Source Information
Document Type
Congressional Bill
Official Title
Access to Birth Control Act
Sponsor
Cosponsors
(25)Data Sources
Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.